Addition of UK based peptide and antibody production facilities expands peptides and biologics business in UK and Europe
Biosynth, a supplier of critical raw materials to the life science industry, has acquired Cambridge Research Biochemicals (CRB), a leading independent producer of custom-made peptide and antibody tools, based in the UK and supplying researchers in the pharmaceutical, life science and academic sectors. Isopropyl Ester
CRB brings a wealth of expertise to Biosynth’s peptide division, which has existing operations in the US and the Netherlands. This includes leading expertise in complex peptide chemistry and fluorescent dye labelling. CRB also brings additional custom antibody capacity in Europe, to support customers through the generation of novel, complex or unusual mono- and poly-clonal antibodies unavailable in catalogs.
Dr Urs Spitz, CEO and President of Biosynth, said, “Having a network of peptide sites at key locations, staffed by industry experts, allows us to best serve our customers throughout research and development and with the most complex and labelled peptides and high quality antibodies.”
Emily Humphrys, Managing Director of Cambridge Research Biochemicals said, “As one of the longest established peptide companies, we have over 40 years of experience and are proud to have a strong track record for peptide and antibody excellence with our customers. We see great similarities in the approach that Biosynth already take in leading with science and customer focus.”
$15 Bn Pharma R&D Spends Ro...
“As Precision Medicine is c...
Why talent and collaboration is cru
Investment in deeptech companies so
Korea's Daewoong Pharma inks $477 M
Industry to improve access to point
Australia lagging behind similar co
Qiagen launches QIAstat-Dx in Japan
India, Korea strengthen ties to boo
Malaysia unveils world’s first trad
Is APAC region poised to play a significant role in shaping pharmaceutical innovation globally?
1 North Bridge Road, #08-08 High Street Centre, Singapore 179094 Email : communications@biospectrumasia.com +65 90150305
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer
Short Peptide Web Interface Conceived and Powered By : SCI Knowledge Interlinks